| Literature DB >> 27152705 |
Caitlin L Maikawa1, Scott Weichenthal, Amanda J Wheeler, Nina A Dobbin, Audrey Smargiassi, Greg Evans, Ling Liu, Mark S Goldberg, Krystal J Godri Pollitt.
Abstract
BACKGROUND: Epidemiological studies have provided strong evidence that fine particulate matter (PM2.5; aerodynamic diameter ≤ 2.5 μm) can exacerbate asthmatic symptoms in children. Pro-oxidant components of PM2.5 are capable of directly generating reactive oxygen species. Oxidative burden is used to describe the capacity of PM2.5 to generate reactive oxygen species in the lung.Entities:
Year: 2016 PMID: 27152705 PMCID: PMC5047770 DOI: 10.1289/EHP175
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Selected characteristics of the 62 children included in the present analysis.
| Variable | Value |
|---|---|
| Demographics | |
| Median age (years) (range) | 10.0 (8–12) |
| Sex | |
| Boys | 43 (69) |
| Girls | 19 (31) |
| Race | |
| Caucasian | 40 (64.5) |
| Black | 12 (19.4) |
| Other | 10 (16.1) |
| Health status | |
| Allergies | 44 (71) |
| Hay fever | 13 (21) |
| Eczema before age 2 years | 17 (27) |
| Asthma attack in previous 12 months | 31 (50) |
| Parental asthma | 36 (58) |
| Medication use during monitoring | |
| Corticosteroids | 27 (44) |
| Rescue medication (short-acting beta agonist) | 18 (29) |
| Median FeNO (ppb) (IQR) | 16.3 (24.8) |
| Values are | |
Daily personal exposure measurements of ambient particulate pollutant metrics.
| Exposure | Number of samples | Mean ± SD | Median | IQR | Minimum/ maximum |
|---|---|---|---|---|---|
| Particulate matter (μg/m3) | |||||
| PM2.5 mass | 249 | 19.3 ± 16.8 | 14.1 | 10.8 | 6.53/101 |
| Oxidative burden (% depletion/m3) | |||||
| Ascorbate | 249 | 0.08 ± 0.04 | 0.07 | 0.06 | 0.009/0.22 |
| Glutathione | 249 | 0.06 ± 0.04 | 0.05 | 0.06 | 0.0003/0.21 |
| Temperature (°C) | 246 | 21.1 ± 1.52 | 21.0 | 2.00 | 16.0/26.0 |
Figure 1Percent change in FeNO per IQR change (95% CI) in ambient pollutant (PM2.5 mass concentration) (A) and oxidative burden (ascorbate- and glutathione-related depletion per cubic meter of air) (B) exposure metrics over 0-, 1-, and 2-day lags. The mixed models included a random effect for each child, a first-order autoregressive correlation structure, and indicators for day (1–10) of the study. Models were adjusted for fixed effects including temperature, sex, presence of allergies, and use of beta-agonists.
Figure 2Effects of glutathione-related oxidative burden exposure per cubic meter of air on the percent change in FeNO over 0-, 1-, and 2-day lags as modified by medication use (any medication, none, corticosteroids, beta-agonists) (A) and presence of allergies (dust, mold, pollen, fur) (B). The mixed models included a random effect for each child, a first-order autoregressive correlation structure, and indicators for day (1–10) of the study. Models were adjusted for fixed effects including temperature, sex, presence of allergies and use of beta-agonists.